Stem cell ban to be lifted
President Obama is set to issue an executive order March 9 overturning Bush administration restrictions on federal funding of embryonic stem cell research, according to reports circulating late Friday, March 6. The eight-year ban restricts NIH support to researchers using a set of cell lines in existence on Aug. 9, 2001, the day President George W. Bush signed the order. Although lifting the ban most directly affects academic research, the halo effect undoubtedly will inspire investors to give biotechs working on regenerative hESC therapeutics a bump. Legislation that amends the Public Health Service Act to allow and regulate the research, introduced this year in the House by Rep. Diana DeGette, D-Colo., and in the Senate by Sen. Tom Harkin, D-Iowa, must still be enacted to establish the policy in statute
You may also be interested in...
Pink Sheet reporters and editor discuss President-Elect Joe Biden’s decision to name the CDER director as acting FDA commissioner and other staffing changes, as well as changes to industry trade groups’ political donations.
Delfi Diagnostics will use the new funds to expand its team of cancer researchers and machine-learning experts to validate its novel approach for early cancer detection through multiple prospective clinical trials.
US Ninth Circuit affirms a district court’s summary judgment in favor of Target and manufacturer of Up & Up brand biotin supplement it sells. Indian manufacturer targeted in putative class-action in New York prompted FDA’s 2016 creation of import alert category for Ayurvedic supplements.